Key result
Interleukins and inflammatory markers play a vital role in the pathogenesis, prognosis, and treatment of atrial fibrillation, and can serve as markers for diagnosis and cardiovascular events.
Why the study?
Atrial fibrillation is a prevalent arrhythmia and major cause of cardiovascular death, prompting evaluation of the role of interleukins and inflammatory mediators in its pathogenesis, prognosis, and treatment.
Interleukins and inflammatory markers play a vital role in the pathogenesis and prognosis of atrial fibrillation and represent potential therapeutic targets.
No takes yet. Share an insight, caveat, or question.
Supports further investigation of interleukins in AF; leaves open clinical utility pending randomized data.
Lotfi et al. (2023) conducted a review in Atrial fibrillation. Interleukins and inflammatory mediators was evaluated. Interleukins and inflammatory markers play a vital role in the pathogenesis, prognosis, and treatment of atrial fibrillation, and can serve as markers for diagnosis and cardiovascular events.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: